Because the serum Folr1 protein secreted by tumor cells in soluble form has been referred as a biomarker of prognosis in ovarian cancer patients [22, 23], we evaluated the soluble Folr1 in serum or CSF as an indicator for MB. Here, FOLR1 is linked to neoplasm.